Cite
Ratner P, Andrews CP, Hampel FC, et al. Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies. Allergy Asthma Clin Immunol. 2017;13:18doi: 10.1186/s13223-017-0183-z.
Ratner, P., Andrews, C. P., Hampel, F. C., Martin, B., Mohar, D. E., Bourrelly, D., Danaietash, P., Mangialaio, S., Dingemanse, J., Hmissi, A., & van Bavel, J. (2017). Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 1318. https://doi.org/10.1186/s13223-017-0183-z
Ratner, Paul, et al. "Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies." Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology vol. 13 (2017): 18. doi: https://doi.org/10.1186/s13223-017-0183-z
Ratner P, Andrews CP, Hampel FC, Martin B, Mohar DE, Bourrelly D, Danaietash P, Mangialaio S, Dingemanse J, Hmissi A, van Bavel J. Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies. Allergy Asthma Clin Immunol. 2017 Apr 04;13:18. doi: 10.1186/s13223-017-0183-z. eCollection 2017. PMID: 28392807; PMCID: PMC5379543.
Copy
Download .nbib